Skip to main content
. 2021 Feb 8;58(4):5. doi: 10.3892/ijo.2021.5185

Figure 1.

Figure 1

ST3GAL6-AS1 is overexpressed in MM and predicts poor prognosis in patients with MM. (A) lncRNA ST3GAL6-AS1 was upregulated in patients with newly diagnosed MM, compared with healthy donors. Expression level of ST3GAL6-AS1 was related to (B) ISS, (C) R-ISS and (D) mSMART stage. *P<0.05, **P<0.01, ***P<0.001 vs. respective control. MM, multiple myeloma; lnc, long non-coding; R-ISS Revised International Staging System; ISS, International Staging System; Inter, intermediate. mSMART; Mayo Stratification of Myeloma and Risk-Adapted Therapy.